Johnson & Johnson Forecasts $2.5 Billion In COVID-19 Vaccine Sales

Johnson & Johnson on Wednesday forecast just $2.5 billion in 2021 sales of its COVID-19 vaccine, which has fallen way behind rival shots from Pfizer and Moderna as the company deals with vaccine…

Leave a Reply

Your email address will not be published. Required fields are marked *

error: Content is protected !!